Financials data is unavailable for this security.
Cash flow in SEKView more
In 2023, Modus Therapeutics Holding AB increased its cash reserves by 82.85%, or 8.64m. Cash Flow from Financing totalled 25.32m or -- of revenues. In addition the company used 16.68m for operations while cash from investing was breakeven.
Cash flow per share | -0.5424 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.2738 |
---|---|
Tangible book value per share | 0.2738 |
More ▼
Balance sheet in SEKView more
Current ratio | 4.65 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼